Company Performance: Afyx Therapeutics' financial health, including revenue, earnings, and profitability, significantly influences its stock price.

Industry Trends: Developments within the pharmaceutical and biotechnology sectors, such as regulatory changes or competitor advancements, can impact investor sentiment.

Market Conditions: Broader economic factors, like interest rates, inflation, and overall market volatility, play a crucial role in determining investor risk appetite and stock valuations.

Clinical Trial Results: Outcomes from Afyx's clinical trials for its drug candidates are critical. Positive results can boost the stock price, while negative results can cause it to decline.

Regulatory Approvals: The approval or rejection of Afyx's products by regulatory bodies, such as the EMA or FDA, is a major driver of stock price fluctuations.

Investor Sentiment: Overall market perception and investor confidence in Afyx's potential impact its stock value.

News and Events: Company-specific news, announcements, partnerships, acquisitions, and other significant events can trigger immediate stock price movements.